GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SOC Telemed Inc (NAS:TLMD) » Definitions » Debt-to-EBITDA

SOC Telemed (SOC Telemed) Debt-to-EBITDA : -2.68 (As of Dec. 2021)


View and export this data going back to 2020. Start your Free Trial

What is SOC Telemed Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

SOC Telemed's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2021 was $0.03 Mil. SOC Telemed's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2021 was $86.75 Mil. SOC Telemed's annualized EBITDA for the quarter that ended in Dec. 2021 was $-32.40 Mil. SOC Telemed's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2021 was -2.68.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for SOC Telemed's Debt-to-EBITDA or its related term are showing as below:

TLMD's Debt-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.57
* Ranked among companies with meaningful Debt-to-EBITDA only.

SOC Telemed Debt-to-EBITDA Historical Data

The historical data trend for SOC Telemed's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOC Telemed Debt-to-EBITDA Chart

SOC Telemed Annual Data
Trend Dec19 Dec20 Dec21
Debt-to-EBITDA
-21.35 - -2.68

SOC Telemed Semi-Annual Data
Dec19 Dec20 Dec21
Debt-to-EBITDA -21.35 - -2.68

Competitive Comparison of SOC Telemed's Debt-to-EBITDA

For the Medical Care Facilities subindustry, SOC Telemed's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SOC Telemed's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SOC Telemed's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where SOC Telemed's Debt-to-EBITDA falls into.



SOC Telemed Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

SOC Telemed's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.025 + 86.752) / -32.396
=-2.68

SOC Telemed's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.025 + 86.752) / -32.396
=-2.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Dec. 2021) EBITDA data.


SOC Telemed  (NAS:TLMD) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


SOC Telemed Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of SOC Telemed's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


SOC Telemed (SOC Telemed) Business Description

Traded in Other Exchanges
N/A
Address
1768 Business Center Drive, Suite 100, Reston, VA, USA, 20190
SOC Telemed Inc is a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare systems based on number of clients. It provides technology enabled clinical solutions which include acute teleNeurology, telePsychiatry, and teleICU, and telePulmonology service. It supports specialty care, providing time-sensitive specialty care when patients are vulnerable and may not otherwise have access. Its solution was developed to support complex workflows in the acute care setting by integrating cloud-based software platform, Telemed IQ, with a panel of patient advocates and a network of clinical specialists to create a seamless, acute telemedicine solution.
Executives
Robert Jason Hallock officer: Chief Medical Officer C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
David R. Fletcher officer: Interim CFO C/O SOC TELEMED, INC., 1768 BUSINESS CENTER DRIVE, SUITE 100, RESTON VA 20190
David Mikula officer: Chief Operating Officer C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Gyasi C. Chisley director C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Christopher M. Gallagher director C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Steven J Shulman director 1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Christopher K Knibb officer: Chief Financial Officer C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Warburg Pincus Partners Ii, L.p. director, 10 percent owner 450 LEXINGTON AVENUE, C/O WARBURG PINCUS LLC, NEW YORK NY 10017
Anne Mcgeorge director C/O MAGENTA THERAPEUTICS, INC., 100 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE MA 02139
Wpxi Finance, Lp director, 10 percent owner C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Wpxi Gp, L.p. director, 10 percent owner C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Warburg Pincus & Co. director, 10 percent owner 450 LEXINGTON AVENUE, NEW YORK, NY NY 100173147
Amr Kronfol director C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Joseph P Greskoviak director C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Sean Banerjee officer: Chief Technology Officer C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190